Future Therapies and Clinical Trials
The diagnosis and treatment of osteoporosis is still a relatively young science. Although Albright first described osteoporosis in 19471 it is only since the late 1980s and early 1990s that we have had the instruments available to us for the diagnosis and then treatment of this disease. Like any medical area in its infancy, we can therefore expect a significant number of changes in the coming years, as the understanding of bone physiology becomes more comprehensive and the genetic factors leading to increased risk factors become known.
KeywordsAnorexia Nervosa Osteogenesis Imperfecta Future Therapy Bone Physiology Male Osteoporosis
Unable to display preview. Download preview PDF.
- 1.Albright F. Annals of Internal Medicine Volume 27, 1947: Osteoporosis. Nutr Rev 1989; 47: 85–6.Google Scholar
- 3.Lindsay R, Cosman F, Lobo RA, Walsh BW, Harris ST, Reagan JE, Liss CL, Melton ME, Byrnes CA. Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial. J Clin Endocrinol Metab 1999; 84 (9): 3076–81.PubMedCrossRefGoogle Scholar